Post-Colonial Mosambic Narrative: Constants and Singularities

The present thesis analyzes the tendencies of the contemporary Mozambican narrative prose (novel). Taking into account the fact that Mozambican literature is an emerging and post-colonial one, the analysis is focused on the issue of how a literature participates in the process of consolidation of the national/cultural identity of this country. This thesis studies three important subjects of the Mozambican narrative prose: language (parting from the work of Mia Couto), history (based on the works by Ungulani Ba Ka Khosa, João Paulo Borges Coelho and Lília Momplé) and tradition (examining two novels by Paulina Chiziane). Key-words: Mozambique, Post-colonial, 20th century Mozambican Literature Language, History, Tradition, Mozabicanit

Additional file 6 of Change in weight and waist circumference and risk of colorectal cancer: results from the Melbourne Collaborative Cohort Study

Risk of colorectal cancer in relation to categories of change in anthropometric measures: Hazard ratios and 95 % CI. (PDF 92.5 kb

Additional file 1: of Mammographic density and risk of breast cancer by mode of detection and tumor size: a case-control study

Table S1. Risk of breast cancer for BMI and mammographic measures by detection mode, excluding HRT users. Table S2 Risk of breast cancer for BMI and mammographic measures by detection mode and tumor size, excluding HRT users. Table S3 Risk of interval versus screen-detected cancer for BMI and mammographic measures, excluding HRT users. Table S4 Risk of breast cancer for BMI and mammographic measures by detection mode, excluding cases (and matched controls) diagnosed within 2 years of mammogram. Table S5 Risk of breast cancer for BMI and mammographic measures by detection mode and tumor size, excluding cases (and matched controls) diagnosed within 2 years from mammogram. Table S6 Risk of interval versus screen-detected cancer for BMI and mammographic measures, excluding cases (and matched controls) diagnosed within 2 years from mammogram. Table S7 Risk of breast cancer for BMI and mammographic measures by detection mode, excluding cases diagnosed between 1 and 2 years after negative screening, and their matching controls. Table S8 Risk of breast cancer for BMI and mammographic measures by detection mode and tumor size, excluding cases diagnosed between 1 and 2 years after negative screening, and their matching controls. Table S9 Risk of interval versus screen-detected cancer for BMI and mammographic measures, excluding cases diagnosed between 1 and 2 years after negative screening, and their matching controls. (DOCX 61 kb

Hazard Ratios (95% Confidence Interval) for all-cause mortality in relation to change in body size by age group at baseline.

a<p>Estimates adjusted for sex, country of birth, quintile of socioeconomic status, body size at baseline, cumulative smoking status, and the following covariates measured at baseline and wave 2: physical activity, Mediterranean diet score and living alone.</p

Hazard Ratios (95% Confidence Interval) for all-cause mortality in relation to change in body size.

a<p>Model 1: Estimates adjusted for sex and country of birth.</p>b<p>Model 2: Estimates adjusted for sex, country of birth, quintile of socioeconomic status, body size at baseline, cumulative smoking status, and the following covariates measured at baseline and wave 2: physical activity, Mediterranean diet score and living alone.</p

Clinical details of the 19 <i>HOXB13</i> missense mutation G84E carriers (rs138213197), their male relatives and their mothers at baseline, sufficient to calculate the penetrance estimates.^*

*<p>B, brother; F, father; HB, half-brother; MU, maternal uncle; MGF, maternal grandfather; PU, paternal uncle; PGF, paternal grandfather; S, son.</p><p>Observation time began at date of birth and ended at the earliest of the following: date of diagnosis of prostate cancer, date at death, or 31 Dec 2011. Carrier status: + carrier, (+) obligate carrier, − non-carrier, ? unknown carrier status.</p

Hazard Ratios (95% Confidence Interval) for death due to obesity-related cancer or CVD in relation to change in body size.

a<p>Estimates adjusted for sex, country of birth, quintile of socioeconomic status, body size at baseline, cumulative smoking status, and the following covariates measured at baseline and wave 2: physical activity, Mediterranean diet score and living alone.</p>b<p>Obesity-related cancers include the following cancers: breast, colorectal, endometrial, oesophageal, kidney, pancreatic.</p

Flowchart of participants in the MCCS.

<p>Flowchart of participants in the MCCS.</p

Penetrance (age-specific cumulative risk) (solid line), and 95% confidence limits intervals (dashed lines), of prostate cancer for carriers of the HOXB13 missense mutation G84E (rs138213197) by selected years of birth.

<p>Penetrance (age-specific cumulative risk) (solid line), and 95% confidence limits intervals (dashed lines), of prostate cancer for carriers of the HOXB13 missense mutation G84E (rs138213197) by selected years of birth.</p

Hazard ratios and 95% confidence intervals for risk of breast cancer in relation to number of nevi, E3N cohort (<i>n = </i>89,802).

a<p>Adjusted for age (timescale), education, menopausal status, age at menopause (in postmenopausal women), use of MHT (in postmenopausal women), and use of premenopausal progestogens, and stratified according to year of birth in 5-y categories.</p>b<p>Model 2 additionally adjusted for personal history of BBD.</p>c<p>Model 3 additionally adjusted for personal history of BBD and family history of breast cancer.</p>d<p>Model 4 additionally adjusted for BMI, height, physical activity, age at menarche, age at first full-term pregnancy, parity, breastfeeding, use of OCs, history of mammographic exam, UV dose in county of birth, and UV dose in county of residence at inclusion.</p